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38S Abstracts May Supplement 2013greater when patients were readmitted to an index vs non-
index facility. No mortality difference was observed.
Conclusions: Readmission to non-index facility after
AAA repair is common (29%) and more frequent than for
the overall Medicare population (22%). Patients from rural
areas and those treated at academic medical centers are
more likely to return to their local hospitals. Quality
improvement efforts to reduce readmissions following
AAA repair will need to account for those patients who
are treated outside the purview of the primary surgeon’s
care.
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Objectives: Unplanned events including readmissions
(URA) and reoperations are of increasing interest in the
current era of medical cost containment. We investigated
the inﬂuence of surgical approach to abdominal aortic
aneurysm (AAA) repair on such events.
Methods: Patients undergoing open (OPEN) or
endovascular (EVAR) non-ruptured AAA repair were iden-
tiﬁed in the 2011 NSQIP database. We examined risk
factors of 30-day rates of URA and reoperation with multi-
variable analyses.
Results: 4925 patients underwent EVAR (76%) or
OPEN (24%) AAA repair. OPEN was associated with
higher rates of reoperation (9% vs 5%; P < .01), wound
infections (3% vs 2%; P ¼ .01), and mortality (5% vs 3%;
P < .01) on univariable analysis. The overall URA rate
was 8%. There was no effect of surgical approach on
URA with univariable (EVAR 8% vs OPEN 8%; P ¼ .65)
or multivariable (EVAR adjusted odds ratio [OR], .7;
95%; conﬁdence interval [CI], .5-1.2; P ¼ .25) analysis.
On multivariable analysis, reoperation was signiﬁcantly
associated with OPEN repair (OR, 1.9; 95% CI, 1.3-2.7;
P < .01), emergency surgery (OR, 2.3; 95% CI, 1.4-3. 8;
P < .01), preoperative dyspnea (OR, 1.9, 95% CI, 1.3-
2.9; P < .01), and coagulopathy (OR, 1.7; 95% CI, 1.1-
2.6; P ¼ .03). Multivariable risk factors for URA were
postoperative occurrences including superﬁcial surgical
site infection (SSI; OR, 6.9; 95% CI, 2.9-16.6; P < .01),
deep SSI (OR, 8.2; 95% CI, 1.7-39.3; P < .01), UTI(OR, 5.9; 95% CI, 2.9-11.8; P < .01), myocardial infarc-
tion (OR, 9.7; 95% CI, 3.5-26; 8; P < .01), pulmonary
embolism (OR, 47.0; 95% CI, 8.4-262.6; P < .01),
progressive renal failure (OR, 4.3; 95% CI, 1.3-14.8; P ¼
.02), and reoperation (OR, 11.1; 95% CI, 6.3-19.5; P <
.01). Among preoperative risk factors, only presurgery
admission (OR, 1.92; 95% CI, 1.27-2.90; P < .01) and
female gender (OR, 1.8; 95% CI, 1.3-2.7; P < .01) were
associated with URA.
Conclusions: While OPEN AAA repair was associated
with higher postoperative reoperation rates, this did
not translate into increased URA rate compared with
EVAR.
Author Disclosures: K. J. Ho: Nothing to disclose; A. L.
Madenci: Nothing to disclose;M. T. Menard: Nothing to
disclose.PS14.
The Natural History and Outcomes for Thoracic and
Abdominal Penetrating Aortic Ulcers
Shaun M. Gifford, Audra Duncan, Lawrence Greiten,
Peter Gloviczki, Gustavo S. Oderich, Manju Kalra, Mark
D. Fleming, Thomas Bower. Vascular Surgery, Mayo
Clinic, Rochester, Minn
Objectives: To deﬁne the natural history of pene-
trating aortic ulcers (PAU) in the descending thoracic
(DTA) and abdominal aorta (AA).
Methods: Data from consecutive patients with PAU
from Jan 1, 1998-Dec 31, 2012 were retrospectively
reviewed. Computed tomography (CT) was analyzed for
anatomical changes. End points were changes in size,
symptoms/rupture, morbidity and mortality.
Results: Ninety-three patients were studied: 20 had
immediate repair (Group 1), 57 were followed with two
or more CTs 3 months apart (Group 2), and 16 had
one CT and no intervention. Group 1 included 13 men,
seven women with a mean age of 70 with 12 DTA and
eight AA PAUs. Group 1 repair indications were: rupture
(three), symptoms (10) or size (seven). Group 1 repairs
included one open and 19 endovascular with 0% 30-day
mortality. Major complications (3/20; 15%) included
MI, access site disruption, and hematoma; 4/20 had
Type II endoleaks. In Group 2, mean age was 75 years
(29 men, 28 women) with 28 DTA and 29 AA PAUs.
Fifty patients were asymptomatic while ﬁve had pain and
two had distal emboli. Mean follow up was 38 months
(range, 3-108). Ulcer growth rate was: length 2.0 mm/
yr, depth 1.2 mm/yr, and aortic diameter 2.2 mm/yr.
Thirteen (23%) went on to repair at a mean of 31 months
after diagnosis, due to size (54%; 7/13), rapid growth
(31%; 4/13), and high-risk morphology (15%; 2/13).
During surveillance 11 patients died; 10 of unrelated
causes and one of rupture after refusing repair. All repairs
in Group 2 were endovascular. 30-day surgical mortality
was 0%. One patient had an access site complication
requiring bypass after DTA PAU repair. At a mean
follow-up of 32 months, all ulcers were excluded on
CT; one (8%) has a type II endoleak.
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low. Endovascular repair of symptomatic, ruptured and
large PAU is safe and effective with excellent long-term
results. For asymptomatic PAU, serial CT surveillance is
associated with a low rate of rupture or complications.
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Objectives: It is unclear whether the type of proximal
ﬁxation and radial force associated with EVAR have any
long-term impact on the aneurysm neck diameter
(AND). We sought to identify whether AND changes
occur and if any factors are associated with changes in
AND.
Methods: Post-EVAR computed tomography images
were reviewed for all patients undergoing EVAR at two
tertiary medical centers between November 2002 and
March 2012 for whom >6 month post-EVAR imaging
was obtained. The AND was deﬁned as the minor axis 1
cm inferior to the lowest renal artery. AND changes were
calculated as the difference between pre-EVAR AND and
AND at last follow-up scan. EVAR stent-graft type and
other patient characteristics were obtained from chart
review. Multivariable linear regression was used to identify
factors independently associated with long-term AND
changes.
Results: A total of 151 patients meeting inclusion
criteria underwent EVAR with one of ﬁve stent-graft
types. The median age was 70 years old, and median
follow-up time for these patients was 2.05 years. The
mean initial AND was 24.5 mm, and the median AND
change was -0.2 mm/yr. AND expansion >1 mm/yr
occurred in 27 patients (17.8%). Multivariable regression
demonstrated that larger initial AND (P ¼ .001) and dia-
betes mellitus (P ¼ .03) were associated with reduced
risk of AND expansion. The Zenith (P < .001) and
the Talent (P ¼ .07) stent-grafts were associated with
increased risk of AND expansion compared to Excluder,
Aneurx, and Powerlink devices. Overall, stent-grafts with
suprarenal ﬁxation were associated with increased rate of
AND expansion compared to those that did not have
suprarenal ﬁxation (P ¼ .01).
Conclusions: Signiﬁcant AND expansion after
EVAR is uncommon. Necks that do expand only do
so marginally but suprarenal ﬁxation appears to beassociated with an increased risk of long-term AND
expansion. Future studies should address the incidence
of AND during longer follow up and the relationship
between AND expansion and secondary interventions
after EVAR.
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Objectives: There are limited data describing the
“Preclose” technique in TEVAR (P-TEVAR), particularly
in obese patients (BMI $ 30kg/m2), in whom this tech-
nique is thought to be contraindicated. We describe our
experience with P-TEVAR and compare outcomes in
obese and nonobese patients.
Methods: All patients undergoing TEVAR at a single
institution from ’05-11 were reviewed; patients under-
going P-TEVAR were identiﬁed and stratiﬁed by BMI.
Technical success was deﬁned as the ability to achieve
hemostasis and maintain limb perfusion without the need
for surgical repair of the vessel.
Results: Of 536 TEVARs, 359 (67%) P-TEVAR
procedures were completed. For the entire P-TEVAR
cohort, mean age 6 SD was 62.9 6 15.7 yrs with BMI
of 27.56 5.4. Mean sheath diameter, largest TEVAR stent
diameter, and number of Perclose deployments were 22.4
6 2.5F, 34.6 6 7.8 mm and 2.1 6 0.4, respectively. Mean
access vessel inner diameter was 8.0 6 2.0 mm with
average depth of 35.6 6 17.5 mm. Adjunctive iliac stents
were used in 9.4% (n ¼ 34). Overall “Preclose” success
rate was 92.6%:92.2% for nonobese patients and 93.8%
for obese patients (P ¼ .57). 3 patients required subse-
quent operations for access complications: two obese
patients (2%) and one nonobese patient (0.3%). By univar-
iate analysis, higher age, increased sheath size, larger aortic
stent diameter, use of more than 2 Perclose devices, need
for iliac stents, and higher femoral artery calcium score
were associated with failure. Independent predictors of
failure were adjunctive iliac stent (OR, 8.9; 95% CI, 2.9-
27.4; P ¼ .003), >2 Perclose devices (OR, 6.7; 95% CI,
2.2-20.2; P ¼ .001), and decreased access vessel diameter
(OR, 1.5; 95% CI, 1.1-2; P ¼ .008).
Conclusions: Percutaneous endovascular repair of
thoracic aortic pathology is safe. Obesity does not appear
to be a contraindication for the “Preclose” technique.
Patients predicted to need adjunctive stenting or possessing
smaller access vessel diameters with greater degree of calci-
ﬁcation are at highest risk of failure and selective use of this
technique is recommended.
